Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro

Scandinavian Journal of Immunology

Volumn 46, Issue 4, 1997, Pages 358-365

  Halaas, O ^a,b   Olsen, W M ^b   Veiby, O P ^b   Lovhaug D ^b   Skjak Braek G ^a   Vik, R ^a   Espevik, T ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; MANNAN; MANNURONAN; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; DOSE RESPONSE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE;

EID: 0030839364     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-138.x     Document Type: Article

References (35)

1. Walker RI. Acute radiation injuries. Pharmacol Ther 1988;39:9-12.
2. Patchen ML, D'Alesandro MM, Brook I, Blakely WF, MacVittie TJ. Glucan: mechanisms involved in its 'radioprotective' effect. J Leukoc Biol 1987;42:95-105.
3. Ainsworth EJ. From endotoxins to newer immunomodulators: survival-promoting effects of microbial polysaccharide complexes in irradiated animals. Pharmacol Ther 1988;39:223-41.
4. Patchen ML, MacVittie TJ, Solberg BD, Souza LM. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor. Exp Hematol 1990;18:1042-8.
5. Patchen ML, MacVittie TJ. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol 1985;7:923-32.
6. Otterlei M, Sundan A, Skjåk-Bræk G, Ryan L, Smidsrød O, Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun 1993;61:1917-25.
7. Otterlei M, Østgaard K, Skjåk-Bræk G, Smidsrød O, Soon Shiong P, Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991;10:286-91.
8. Espevik T, Otterlei M, Skjåk-Bræk G, Ryan L, Wright SD, Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 1993;23:255-61.
9. Jahr TG, Ryan L, Sundan A, Lichenstein HS, Skjåk-Bræk G, Espevik T. Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/ permeability-increasing factor. Infect Immun 1997;65:89-94.
10. Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol 1993;53:267-89.
11. Stanley ER. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol 1985;116:564-87.
12. Spangrude GJ, Scollay R. A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol 1990;18:920-6.
13. Fazekas de St Groth S. The evaluation of limiting dilution analysis. J Immunol Methods 1982;49:R11-23.
14. Mather K. The analysis of extinction time data in bioassay. Biometrics 1949;June:127-43.
15. 1H-n.m.r. spectroscopy of alginate: sequential structure and linkage conformation. Carbohydr Res 1983;118:255-60.
16. Staros JV, Wright RW, Swingle DM. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem 1986;156:220-2.
17. Bøyum AM. Separation of monocytes and lymphocytes. Scand J Immunol 1976;5:9-15.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
19. Espevik T, Nissen Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
20. 3 U/ ml of interleukin-2. J Immunol Methods 1987;99:7-11.
21. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
22. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-16.
23. Daley L, Pier GB, Liporace JD, Eardley DD. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol 1985;134:3089-93.
24. Mangan DF, Welch GR, Wahl SM. Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 1991;146:1541-6.
25. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
26. Zucali JR. Mechanisms of protection of hematopoietic stem cells from irradiation. Leuk Lymphoma 1994;13:27-32.
27. Frey EA, Miller DS, Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-71.
28. Ziegler Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121-5.
29. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995;181:857-66.
30. Pedron T, Girard R, Turco SJ, Chaby R. Phosphatidylmositol-anchored molecules and inducible lipopolysaccharide binding sites of human and mouse bone marrow cells. J Biol Chem 1994;269:2426-32.
31. Chaby R, Pedron T, Stutz PL, Girard R. Lipopolysaccharide and tumor necrosis factor-alpha induce lipopolysaccharide receptor expression on bone marrow cells by different mechanisms. J Immunol 1993;151:4476-85.
32. Girard R, Pedron T, Chaby R. Endotoxin-induced expression of endotoxin binding sites on murine bone marrow cells. J Immunol 1993;150:4504-13.
33. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid antigens on normal and malignant cells. J Clin Invest 1981;68:932-41.
34. Ferrero E, Hsieh CL, Francke U, Goyert SM. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J Immunol 1990;145:331-6.
35. Czop JK, Austen KF. A β-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol 1985;134:2588-93.